MBCL-05. TREATMENT OF CHILDREN WITH MEDULLOBLASTOMA WITHOUT METASTATIC INVOLVEMENT IN THE AGE GROUP OLDER THAN 3 YEARS: RESULTS OF INTERCENTER TRIAL

The aim of this study was to identify a group of patients aged 3 to 7 years for whom there is the possibility for reducing of craniospinal radiation dose (CSI). From 2008 to 2018 fifty one pediatric patients with primary diagnosed medulloblastoma in the age group 3 - 18 years were included in trial,...

Descripción completa

Detalles Bibliográficos
Autores principales: Levashov, Andrey, Stroganova, Anna, Khochenkov, Dmitry, Zagidullina, Svetlana, Babelyan, Stepan, Ryzhova, Marina, Gorelyshev, Sergey, Kadirov, Shavkat, Subbotina, Natalya, Daylidite, Vidmante, Sidelnikov, Dmitry, Mentkevich, Georgy, Grigorenko, Vasily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Medulloblastoma (Clinical)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715623/
http://dx.doi.org/10.1093/neuonc/noaa222.481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715623/
http://dx.doi.org/10.1093/neuonc/noaa222.481

Ejemplares similares